JP2016504040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504040A5 JP2016504040A5 JP2015551870A JP2015551870A JP2016504040A5 JP 2016504040 A5 JP2016504040 A5 JP 2016504040A5 JP 2015551870 A JP2015551870 A JP 2015551870A JP 2015551870 A JP2015551870 A JP 2015551870A JP 2016504040 A5 JP2016504040 A5 JP 2016504040A5
- Authority
- JP
- Japan
- Prior art keywords
- chromatography
- asa
- purified recombinant
- protein
- ultrafiltration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750693P | 2013-01-09 | 2013-01-09 | |
| US61/750,693 | 2013-01-09 | ||
| PCT/US2014/010856 WO2014110246A1 (en) | 2013-01-09 | 2014-01-09 | Methods for purification of arylsulfatase a |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018122837A Division JP2018171067A (ja) | 2013-01-09 | 2018-06-28 | アリールスルファターゼａの精製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016504040A JP2016504040A (ja) | 2016-02-12 |
| JP2016504040A5 true JP2016504040A5 (enExample) | 2017-02-16 |
| JP6427502B2 JP6427502B2 (ja) | 2018-11-21 |
Family
ID=50002885
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015551870A Active JP6427502B2 (ja) | 2013-01-09 | 2014-01-09 | アリールスルファターゼａの精製方法 |
| JP2018122837A Withdrawn JP2018171067A (ja) | 2013-01-09 | 2018-06-28 | アリールスルファターゼａの精製方法 |
| JP2019174155A Withdrawn JP2020015750A (ja) | 2013-01-09 | 2019-09-25 | アリールスルファターゼａの精製方法 |
| JP2021183082A Active JP7407161B2 (ja) | 2013-01-09 | 2021-11-10 | アリールスルファターゼａの精製方法 |
| JP2023173170A Active JP7663649B2 (ja) | 2013-01-09 | 2023-10-04 | アリールスルファターゼａの精製方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018122837A Withdrawn JP2018171067A (ja) | 2013-01-09 | 2018-06-28 | アリールスルファターゼａの精製方法 |
| JP2019174155A Withdrawn JP2020015750A (ja) | 2013-01-09 | 2019-09-25 | アリールスルファターゼａの精製方法 |
| JP2021183082A Active JP7407161B2 (ja) | 2013-01-09 | 2021-11-10 | アリールスルファターゼａの精製方法 |
| JP2023173170A Active JP7663649B2 (ja) | 2013-01-09 | 2023-10-04 | アリールスルファターゼａの精製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11407984B2 (enExample) |
| EP (1) | EP2943568B1 (enExample) |
| JP (5) | JP6427502B2 (enExample) |
| CN (4) | CN112126634A (enExample) |
| AU (3) | AU2014205441B2 (enExample) |
| BR (1) | BR112015015948B1 (enExample) |
| CA (1) | CA2896979C (enExample) |
| EA (1) | EA030551B1 (enExample) |
| ES (1) | ES2768261T3 (enExample) |
| HK (1) | HK1214622A1 (enExample) |
| MX (2) | MX372711B (enExample) |
| WO (1) | WO2014110246A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2729566B1 (en) * | 2011-07-08 | 2017-03-15 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
| EP2943568B1 (en) | 2013-01-09 | 2019-11-20 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
| US20160176921A1 (en) * | 2014-12-22 | 2016-06-23 | Alexion Pharmaceuticals, Inc. | Methods of purifying recombinant proteins |
| EP3337819B1 (en) * | 2015-08-20 | 2024-02-21 | F. Hoffmann-La Roche AG | Method of purifying for producing recombinant polypeptides using fkpa |
| WO2017160636A1 (en) * | 2016-03-16 | 2017-09-21 | Shire Human Genetic Therapies, Inc. | Methods of purifying collagen 7 |
| US11584777B2 (en) | 2017-08-31 | 2023-02-21 | Green Cross Corporation | Method for purifying a sulfatase protein |
| AU2018393045C1 (en) * | 2017-12-19 | 2025-10-09 | Takeda Pharmaceutical Company Limited | Purified arylsulfatase A and compositons thereof |
| SG11202006506TA (en) * | 2018-02-02 | 2020-08-28 | Enzyvant Therapeutics Gmbh | Methods for treating farber disease |
| MA52204A (fr) * | 2018-04-12 | 2021-02-17 | Amgen Inc | Procédés de préparation de compositions protéiques stables |
| CN112082832B (zh) * | 2019-06-12 | 2022-03-29 | 华南理工大学 | 一种保存城市污水中硫酸酯结合体和葡萄糖苷醛酸结合体的方法 |
| KR102286892B1 (ko) * | 2019-07-08 | 2021-08-06 | 삼천당제약주식회사 | 안과용 단백질 제제의 정제방법 |
| CN110632052A (zh) * | 2019-10-25 | 2019-12-31 | 山西师范大学 | 土壤芳基硫酸酯酶活性的荧光光谱检测法 |
| AU2020401034B2 (en) * | 2019-12-12 | 2024-08-29 | Eli Lilly And Company | Methods for viral inactivation by environmentally compatible detergents |
| CN112759643B (zh) * | 2021-03-17 | 2023-05-30 | 华兰生物工程股份有限公司 | 一种血清白蛋白的脱脂方法 |
| CN116693659B (zh) * | 2023-07-11 | 2025-03-28 | 浙江大学 | 一种分离重组人血白蛋白的两步混合模式层析方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315919A (en) | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
| US4314997A (en) | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
| US4764369A (en) | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
| CA2041280A1 (en) | 1990-05-10 | 1991-11-11 | Yosuke Sawada | Arylsulfatase |
| NO960163D0 (no) | 1996-01-15 | 1996-01-15 | Thomas Berg | Mutasjonsdeteksjon av bovin |
| ATE217799T1 (de) | 1998-01-27 | 2002-06-15 | Hemebiotech As | Behandlung von akuter intermittierender porphyria oder anderen porphyrischen krankheiten |
| IL140155A (en) | 1998-06-09 | 2005-12-18 | Statens Seruminstitut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| JP4685238B2 (ja) | 1998-06-09 | 2011-05-18 | ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト | 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法 |
| AUPQ026799A0 (en) | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
| JP2003505057A (ja) | 1999-07-27 | 2003-02-12 | ヘム−バイオテック エイ／エス | ｒｈＰＢＧＤの製造及び急性間欠性ポルフィリン症（ＡＩＰ）及び他のポルフィリン症の患者を処置するための新規な治療方法 |
| US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| AU2002232803A1 (en) | 2000-11-15 | 2002-05-27 | Genzyme Corporation | Expression system for recombinant proteins |
| WO2002098455A2 (en) * | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
| WO2002099092A2 (en) | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human lysosomal alpha-mannosidase |
| WO2003002731A1 (en) | 2001-06-29 | 2003-01-09 | Hemebiotech A/S | A PROCESS FOR PURIFICATION OF RECOMBINANT PORPHOBILINOGEN DEAMINASE (rhPBGD) |
| US7232670B2 (en) | 2001-09-28 | 2007-06-19 | St. Jude Children's Research Hospital | Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| ES2496493T3 (es) | 2002-01-11 | 2014-09-19 | Bioasis Technologies Inc. | Uso de p97 como sistema de administración de enzimas para la administración de enzimas lisosómicas terapéuticas |
| US7118675B2 (en) | 2002-02-04 | 2006-10-10 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
| JP4586027B2 (ja) | 2004-01-30 | 2010-11-24 | シャイア ファーマシューティカルズ アイルランド リミテッド | 組換えアリールスルファターゼａの製造及び精製 |
| WO2005094874A1 (en) | 2004-04-01 | 2005-10-13 | Zymenex A/S | Medical use of alpha-mannosidase |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| MX2008012748A (es) | 2006-04-04 | 2009-01-07 | Shire Pharmaceuticals Ireland | Un proceso para la concentracion de un polipeptido. |
| CA2739352C (en) * | 2008-10-29 | 2021-07-13 | Wyeth Llc | Methods for purification of single domain antigen binding molecules |
| US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| AU2011270670B2 (en) * | 2010-06-25 | 2017-01-12 | Takeda Pharmaceutical Company Limited | Methods and compositions for CNS delivery of arylsulfatase A |
| EP2588130B1 (en) | 2010-06-25 | 2016-08-17 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| EP2943568B1 (en) | 2013-01-09 | 2019-11-20 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
-
2014
- 2014-01-09 EP EP14701454.2A patent/EP2943568B1/en active Active
- 2014-01-09 CN CN202011058581.6A patent/CN112126634A/zh active Pending
- 2014-01-09 CN CN201480003307.5A patent/CN104903442A/zh active Pending
- 2014-01-09 AU AU2014205441A patent/AU2014205441B2/en active Active
- 2014-01-09 WO PCT/US2014/010856 patent/WO2014110246A1/en not_active Ceased
- 2014-01-09 CN CN202510851520.1A patent/CN120665836A/zh active Pending
- 2014-01-09 EA EA201590826A patent/EA030551B1/ru not_active IP Right Cessation
- 2014-01-09 US US14/759,645 patent/US11407984B2/en active Active
- 2014-01-09 CA CA2896979A patent/CA2896979C/en active Active
- 2014-01-09 ES ES14701454T patent/ES2768261T3/es active Active
- 2014-01-09 CN CN202510351647.7A patent/CN119979504A/zh active Pending
- 2014-01-09 HK HK16102496.7A patent/HK1214622A1/zh unknown
- 2014-01-09 MX MX2015008875A patent/MX372711B/es active IP Right Grant
- 2014-01-09 JP JP2015551870A patent/JP6427502B2/ja active Active
- 2014-01-09 BR BR112015015948-6A patent/BR112015015948B1/pt active IP Right Grant
-
2015
- 2015-07-08 MX MX2020003798A patent/MX2020003798A/es unknown
-
2018
- 2018-06-28 JP JP2018122837A patent/JP2018171067A/ja not_active Withdrawn
-
2019
- 2019-09-25 JP JP2019174155A patent/JP2020015750A/ja not_active Withdrawn
-
2020
- 2020-02-14 AU AU2020201079A patent/AU2020201079B2/en active Active
-
2021
- 2021-11-10 JP JP2021183082A patent/JP7407161B2/ja active Active
-
2022
- 2022-07-01 US US17/810,396 patent/US11884945B2/en active Active
- 2022-08-25 AU AU2022221475A patent/AU2022221475B2/en active Active
-
2023
- 2023-10-04 JP JP2023173170A patent/JP7663649B2/ja active Active
- 2023-12-22 US US18/394,404 patent/US12319940B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2553095B1 (en) | A process for purifying vitamin K dependent proteins such as coagulation factor IX | |
| JP6836562B2 (ja) | 治療タンパク質の精製方法 | |
| RU2647835C2 (ru) | Стабилизатор для гиалуронидазы и жидкая композиция, содержащая гиалуронидазу | |
| JP2022023225A (ja) | アリールスルファターゼａの精製方法 | |
| WO2009156430A1 (en) | A process of purifying coagulation factor viii | |
| JP2014501251A (ja) | トランスジェニックイネの子実からヒト血清アルブミンを精製する方法 | |
| JPH10506924A (ja) | 動物性タンパク質を含まないエリトロポイエチンの製造のための方法 | |
| JP7086601B2 (ja) | 組換えｔｎｋ－ｔｐａ（テネクテプラーゼ）の単離及び商業生産のための新規精製方法 | |
| US8476054B2 (en) | Thrombin-like enzyme of Agkistrodon acutus | |
| CN102924562A (zh) | 一种人凝血因子ⅷ的干热处理稳定剂及其用途 | |
| JP2004535197A5 (enExample) | ||
| RS50960B (sr) | Postupak za prečišćavanje eritropoetina | |
| JPWO2008120801A1 (ja) | アンチトロンビン組成物の製造方法 | |
| JP2019528242A5 (enExample) | ||
| US20140309408A1 (en) | Method for purifying virus-like particles (vlp) | |
| KR102528707B1 (ko) | 고순도의 히알루로니다제 정제 방법 | |
| HUE027724T2 (hu) | Eljárás G-CSF tisztítására | |
| CN104854122A (zh) | 重组人半乳糖脑苷脂-β-半乳糖苷酶(rhGALC)的纯化 | |
| DE69719382T2 (de) | VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1 | |
| CN115386564B (zh) | 一种尿激酶的纯化方法 | |
| CN105541994B (zh) | 一种血小板生成素或其变体或衍生物的纯化方法 | |
| ES2625511T3 (es) | Métodos para la purificación de arylsulfatasa A | |
| CN106011116A (zh) | 一种人凝血酶的制备方法 | |
| JP2861655B2 (ja) | ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法 | |
| JP2722140B2 (ja) | ヒト尿性トリプシンインヒビターの製造方法 |